flupenthixol has been researched along with Huntington Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carney, AE; Clarke, C; Pratt, WE | 1 |
1 other study(ies) available for flupenthixol and Huntington Disease
| Article | Year |
|---|---|
Administration of neuropeptide Y into the rat nucleus accumbens shell, but not core, attenuates the motivational impairment from systemic dopamine receptor antagonism by α-flupenthixol.
Topics: Animals; Dopamine; Dopamine Antagonists; Flupenthixol; Huntington Disease; Male; Motivation; Neuropeptide Y; Nucleus Accumbens; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Dopamine | 2023 |